A retrospective study assessing the safety and efficacy of Liraglutide alone and sulfonylurea combination therapy in Japanese type II diabetes patients and its association with beta cell function.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Liraglutide (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Oct 2016 New trial record